These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Surgical treatment of spinal deformities in Duchenne muscular dystrophy: a long term follow-up study. Cervellati S; Bettini N; Moscato M; Gusella A; Dema E; Maresi R Eur Spine J; 2004 Aug; 13(5):441-8. PubMed ID: 15108098 [TBL] [Abstract][Full Text] [Related]
63. Surgical treatment of neuromuscular scoliosis: current techniques. Greggi T; Lolli F; Di Silvestre M; Martikos K; Vommaro F; Maredi E; Giacomini S; Baioni A; Cioni A Stud Health Technol Inform; 2012; 176():315-8. PubMed ID: 22744518 [TBL] [Abstract][Full Text] [Related]
64. The relationship of body habitus and respiratory function in Duchenne muscular dystrophy. Chew K; Carey K; Ho G; Mallitt KA; Widger J; Farrar M Respir Med; 2016 Oct; 119():35-40. PubMed ID: 27692145 [TBL] [Abstract][Full Text] [Related]
65. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H; Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484 [TBL] [Abstract][Full Text] [Related]
67. Update on the management of Duchenne muscular dystrophy. Manzur AY; Kinali M; Muntoni F Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451 [TBL] [Abstract][Full Text] [Related]
68. The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Henricson EK; Abresch RT; Cnaan A; Hu F; Duong T; Arrieta A; Han J; Escolar DM; Florence JM; Clemens PR; Hoffman EP; McDonald CM; Muscle Nerve; 2013 Jul; 48(1):55-67. PubMed ID: 23649481 [TBL] [Abstract][Full Text] [Related]
69. The effect of steroid treatment on weight in nonambulatory males with Duchenne muscular dystrophy. Lamb MM; Cai B; Royer J; Pandya S; Soim A; Valdez R; DiGuiseppi C; James K; Whitehead N; Peay H; Venkatesh SY; Matthews D; Am J Med Genet A; 2018 Nov; 176(11):2350-2358. PubMed ID: 30256515 [TBL] [Abstract][Full Text] [Related]
70. A population-based study of scoliosis among males diagnosed with a dystrophinopathy identified by the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). Conway KM; Gedlinske A; Mathews KD; Perlman S; Johnson N; Butterfield R; Hung M; Bounsanga J; Matthews D; Oleszek J; Romitti PA Muscle Nerve; 2022 Feb; 65(2):193-202. PubMed ID: 34787322 [TBL] [Abstract][Full Text] [Related]
71. Hip subluxation and dislocation in Duchenne muscular dystrophy. Chan KG; Galasko CS; Delaney C J Pediatr Orthop B; 2001 Jul; 10(3):219-25. PubMed ID: 11497366 [TBL] [Abstract][Full Text] [Related]
73. Re: Shapiro F, Zurakowski D, Sethna NF. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusion for Duchenne muscular dystrophy scoliosis. Spine 2007;32:2278-83. Turturro F; Rocca B; Montanaro A Spine (Phila Pa 1976); 2008 Apr; 33(7):827; author reply 827-8. PubMed ID: 18379414 [No Abstract] [Full Text] [Related]
74. Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Spurney C; Shimizu R; Morgenroth LP; Kolski H; Gordish-Dressman H; Clemens PR; Muscle Nerve; 2014 Aug; 50(2):250-6. PubMed ID: 24395289 [TBL] [Abstract][Full Text] [Related]
75. The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review. Szabo SM; Salhany RM; Deighton A; Harwood M; Mah J; Gooch KL Orphanet J Rare Dis; 2021 May; 16(1):237. PubMed ID: 34022943 [TBL] [Abstract][Full Text] [Related]
76. Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy. Sawnani H; Horn PS; Wong B; Darmahkasih A; Rybalsky I; Shellenbarger KC; Tian C; Rutter MM; Simakajornboon N; Amin R; Gurbani N; Pascoe J; Burrows C; Khirani S; Amaddeo A; Fauroux B J Pediatr; 2019 Jul; 210():194-200.e2. PubMed ID: 30955791 [TBL] [Abstract][Full Text] [Related]
77. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C. Villa CR; Kaddourah A; Mathew J; Ryan TD; Wong BL; Goldstein SL; Jefferies JL Neuromuscul Disord; 2016 Oct; 26(10):637-642. PubMed ID: 27542440 [TBL] [Abstract][Full Text] [Related]
78. [Characteristics in the treatment of scoliosis in muscular diseases]. Forst R; Forst J; Heller KD; Hengstler K Z Orthop Ihre Grenzgeb; 1997; 135(2):95-105. PubMed ID: 9214180 [TBL] [Abstract][Full Text] [Related]
79. Outcomes of Primary Posterior Spinal Fusion for Scoliosis in Spinal Muscular Atrophy: Clinical, Radiographic, and Pulmonary Outcomes and Complications. Holt JB; Dolan LA; Weinstein SL J Pediatr Orthop; 2017 Dec; 37(8):e505-e511. PubMed ID: 28777284 [TBL] [Abstract][Full Text] [Related]